Habeeba Bader
About Habeeba Bader
Habeeba Bader is a Senior Clinical Trial Monitor at Bristol Myers Squibb in Toronto, Ontario, Canada, with extensive experience in clinical research and pharmacology.
Current Role at Bristol Myers Squibb
Habeeba Bader is currently employed as a Senior Clinical Trial Monitor at Bristol Myers Squibb in Toronto, Ontario, Canada. She began her role at Bristol Myers Squibb on January 1, 2021. In this capacity, she ensures that clinical trials are conducted, recorded, and reported in compliance with ICH-GCP, protocol, SOPs, and all other regulatory requirements.
Previous Experience at DOCS
Habeeba Bader worked as a Senior Clinical Trial Monitor at DOCS from 2018 to 2020 in Toronto, Ontario, Canada. During her two-year tenure, she specialized in site management and the monitoring of clinical trials, ensuring adherence to all applicable regulatory requirements.
Role at Syneos Health Clinical Solutions
Habeeba Bader served as a Senior Clinical Research Associate at Syneos Health Clinical Solutions from 2017 to 2018 for 9 months in the Toronto, Canada Area. In this role, she was responsible for monitoring clinical trials and ensuring compliance with ICH-GCP guidelines and study protocols.
Educational Background in Pharmacology
Habeeba Bader holds a Master of Pharmacy in Pharmacology and a Bachelor of Pharmacy, both from Jawaharlal Nehru Technological University. She completed her Master's degree between 2008 and 2011 and her Bachelor's degree from 2004 to 2008. Her advanced education provides her with a solid background in pharmacology and clinical research.
Clinical Research and Site Management Experience
Throughout her career, Habeeba Bader has accumulated extensive experience in clinical research and site management. She has held various roles at organizations including JSS Medical Research, Inflamax Research Inc., and University Health Network. Her career highlights include roles as a Clinical Research Associate and Clinical Data and Study Coordinator, emphasizing her comprehensive understanding of clinical trial processes.